Company intelligence
Combat Medical Ltd
Transforming Cancer Treatments Through World Leading Hyperthermic Technologies
About Combat Medical Ltd
Innovative medical device company and manufacturers of the COMBAT BRS (Bladder) and COMBAT PRS (Peritoneal) systems. The BRS delivers HIVEC- Hyperthermic Intra-Vesical Chemotherapy treatment through a closed self regulating recirculation system to significantly increase the effectiveness of Mitomycin C (MMC) in Non Muscle Invasive Bladder Cancer (NMIBC). The PRS delivers HIPEC+ Agitation - Hyperthermic Intraperitoneal Chemotherapy plus agitation to optimise the HIPEC delivery while treating cancers within the peritoneal cavity including ovarian, colo -rectal, pancreatic and gastric. See our website for recently presented clinical evidence on over 500 patients. Both devices have been in clinical use since 2011 and we invest heavily in Clinical trials and R&D to prove our technology. Please see www.combat-medical.com or contact us on +44 1582 834466 for centres offering Hyperthermic Device Assisted Technology with the COMBAT BRS and PRS systems throughout Europe or to find out more about our extensive clinical programme.
Verified activity
Signals from Combat Medical Ltd
3 published signals
Products & Services
Combat Medical Ltd announced the Combat PRS+ Peritoneal Recirculating System, which uses automatic C02 agitation to ensure uniform drug and thermal distribution during closed HIPEC treatments.
Reported by Combat Medical Ltd
Products & Services
Combat Medical Ltd announced the Combat PRS+ Peritoneal Recirculating System, which uses automatic C02 agitation to ensure uniform drug and thermal distribution during closed HIPEC treatments.
Reported by Guy Cooper
Products & Services
Combat Medical Ltd announced the Combat PRS+ Peritoneal Recirculating System, which uses automatic C02 agitation to ensure uniform drug and thermal distribution during closed HIPEC treatments.
Reported by Edward Bruce-White